Heparin – ACT Dynamics: Before and After “New” Heparin (Video)
Jeff Riley discusses observations from the Mayo Clinic regarding the new Heparin that is now on the market (17 minutes).
World's Largest Resource for Cardiovascular Perfusion
Jeff Riley discusses observations from the Mayo Clinic regarding the new Heparin that is now on the market (17 minutes).
HCDs cannot be expected to remain sterile despite extensive decontamination procedures. However, airborne transmission of microorganisms directly from the HCD to the operating field appears unlikely.
This study presents the first European clinical experience with the Medos DeltaStream DP1, a new pulsatile flow pump, in neonates and infants.